NetScientific
plc
("NetScientific", the
"Group" or the
"Company")
Result of Annual General
Meeting
Change of name of Nominated
Adviser and Broker
NetScientific Plc (AIM: NSCI), the
deep tech and life sciences VC investment group, announces that all
resolutions set out in the 2024 Notice of Annual General Meeting
sent to shareholders were duly passed at the Company's Annual
General Meeting held earlier today.
Result of Annual General Meeting
Resolutions 1 to 6 were passed as
Ordinary Resolutions and Resolution 7 was passed as a Special
Resolution. The proxy voting results are as follows:
Resolution
|
For
|
%
|
Against
|
%
|
Vote
Total
|
Vote Total
as % of Issued Share Capital
|
Withheld*
|
1. To
receive and adopt the Company's Annual Report and Accounts for the
period ended 31 December 2023
|
5,242,260
|
100.0%
|
0
|
0.0%
|
5,242,260
|
21.9%
|
0
|
2. To
receive and approve the Directors' Remuneration Report
|
5,199,678
|
99.2%
|
42,570
|
0.8%
|
5,242,248
|
21.9%
|
12
|
3. To
reappoint BDO LLP as the auditors for the forthcoming
year
|
5,236,319
|
99.9%
|
5,941
|
0.1%
|
5,242,260
|
21.9%
|
0
|
4. To
authorise the Audit Committee in determining the Auditors'
remuneration
|
5,242,260
|
100.0%
|
0
|
0.0%
|
5,242,260
|
21.9%
|
0
|
5. To
confirm the reappointment of Dr Ilian Iliev as a
director
|
5,237,162
|
99.9%
|
5,098
|
0.1%
|
5,242,260
|
21.9%
|
0
|
6. To
authorise the Directors to allot relevant securities pursuant to
section 551 of the Companies Act 2006
|
5,135,560
|
98.2%
|
92,634
|
1.8%
|
5,228,194
|
21.8%
|
14,066
|
7. To
disapply pre-emption rights on the allotment of securities or sale
of treasury shares in connection with a pre-emptive offer or on
allotment of up to 239,458 shares
|
5,067,937
|
96.9%
|
160,257
|
3.1%
|
5,228,194
|
21.8%
|
14,066
|
*
A vote withheld is not a vote in law and is not counted in the
calculation of the proportion of votes "For" or "Against" a
resolution.
Change of Name of Nominated Adviser and
Broker
The Company also announces that its
Nominated Adviser and Broker has changed its name to Panmure
Liberum Limited following completion of its own corporate
merger.
For
more information, please contact:
NetScientific
|
|
Ilian Iliev, CEO
|
Via Belvedere
Communications
|
|
|
Panmure Gordon (UK) Limited (NOMAD and
Broker)
|
|
Emma Earl / Will Goode / Freddy
Crossley / Mark Rogers (Corporate Finance)
Rupert Dearden (Corporate
Broking)
|
+44 (0)20 7886 2500
|
|
|
Belvedere Communications
John West / Llewellyn Angus / Lily
Pearce
|
+44 (0)20 7653 8702
|
About NetScientific
NetScientific plc (AIM: NSCI) is a
deep tech and life sciences VC investment group with an
international portfolio of innovative companies.
NetScientific identifies, invests
in, and builds high growth companies in the UK and
internationally.
The company adds value through the
proactive management of its portfolio, progressing to key value
inflection points, and delivering investment returns through
partial or full liquidity events.
NetScientific differentiates itself
by employing a capital-efficient investment approach, making
judicial use of its balance sheet and syndicating investments
through its wholly owned VC subsidiary, EMV Capital. The group
secures a mixture of direct equity stakes and carried interest
stakes in its portfolio of companies, creating a lean structure
that can support a large portfolio.
NetScientific is headquartered in
London, United Kingdom, and is admitted to trading on AIM, a market
operated by the London Stock Exchange.
www.netscientific.net
www.netscientific.net